Clinical Trials Browser

Phase 3 × Suspended × Glioblastoma × Clear all

NCT02546102 2024-04-03

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

Phase 3 Suspended

Glioblastoma